Cape Investment Advisory »

Recursion Pharmaceuticals shares owned by Cape Investment Advisory

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Cape Investment Advisory from 13F filings

Historical chart of Cape Investment Advisory investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Cape Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Cape Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5k 350 9.86
2023-06-30 $1.9k 250 7.47
2023-03-31 $1.7k 250 6.67

More positions owned by Cape Investment Advisory

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Chevron Corporation (CVX)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Alphabet Cap Stk Cl C (GOOG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Cape Investment Advisory

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
MIC Capital Management UK
Nvidia Corp
Norges Bank Investment Management
Dimensional Fund Advisors
Credit Suisse
Point72 Asset Management
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Recursion Pharmaceuticals